Skip to Content

Tag: Third Quarter (Q3)


Vendors

Resmed cites momentum, continued progress in Q3 

April 30, 2026HME News Staff

SAN DIEGO – Resmed reported revenue increased by 11% to $1.4 billion for the third quarter fiscal year 2026.  Other financial results:  GAAP gross margin up 290 bps to 62.2%; non-GAAP gross margin up 290 bps to 62.8%  GAAP income from operations increased 17%; non-GAAP income from operations up 18%  GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86  Operating cash...

Financial Results, fiscal year 2026, ResMed, Third Quarter (Q3)


Read Full Articlered right arrow icon

Jason Hollar

Vendors

Cardinal Health raises profit growth for Other segment

April 30, 2026HME News Staff

DUBLIN, Ohio – Cardinal Health’s Other segment saw a 31% increase in revenue in the third quarter of fiscal year 2026 to $1.7 billion, driven by growth across the three operating segments, including at-Home Solutions. The company now expects the segment to see profit growth of 36% to 38% for the year. Other financial results Overall revenue increased 11% to $60.9 billion. Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share...

at-Home Solutions, Cardinal Health, Financial Results, fiscal year 2026, Third Quarter (Q3)


Read Full Articlered right arrow icon

Vendors

McKesson reports flat revenues for Medical-Surgical segment 

February 9, 2026HME News Staff

IRVING, Texas – McKesson has reported $3 billion in revenues for the third quarter of fiscal year 2026 for its Medical-Surgical Solutions segment, a 1% increase, driven by higher volumes of specialty pharmaceuticals.  For the segment, operating profit was $265 million, and adjusted segment operating profit was $265 million, a 10% decrease, driven by lower volumes across physician office settings and lower incidence of illness for the season.  McKesson reported $106.2...

Financial Results, fiscal year 2026, McKesson, McKesson Medical-Surgical, Third Quarter (Q3)


Read Full Articlered right arrow icon

Casey Hoyt

Specialty Providers

Viemed’s diversification efforts pay off 

November 12, 2025Theresa Flaherty, Managing Editor

LAFAYETTE, La. – Viemed Healthcare’s sleep business accelerated “meaningfully” in the third quarter of 2025 with a 96% increase in new patient starts year over year. The business will remain a key driver in the company’s push for diversified growth, says CEO Casey Hoyt.  Sleep surges during quarter  Resupply grew 51% year-over-year and 33% sequentially, surpassing its PAP rental base for the first time, said Hoyt on a recent call to discuss the company’s...

2025, diversified growth, sleep business, Third Quarter (Q3), Viemed Healthcare


Read Full Articlered right arrow icon

Also Noted

Insulet sees 31% revenue jump 

November 10, 2025HME News Staff

ACTON, Mass. – Insulet reported Omnipod revenue of $699.2 million for the third quarter of 2025, up 31% over the same quarter in 2024. Of that, U.S. Omnipod revenue was $497.1 million and International Omnipod revenue was $202.1 million. “We delivered strong third quarter results, a testament to our team’s exceptional performance and the transformative power of Omnipod 5 for people living with diabetes,” said Ashley McEvoy,...

2025, Diabetes, Insulet, Omnipod, Third Quarter (Q3)


Read Full Articlered right arrow icon

Providers

AdaptHealth announces another preferred provider agreement 

November 4, 2025HME News Staff

CONSHOHOCKEN, Pa. – AdaptHealth announced as part of its third quarter financial results that it has signed another capitated agreement with a payer representing about 170,000 members.  In August, the company announced it had signed a $1 billion capitated agreement with a major health system, a move it says will accelerate growth in 2026.  For the third quarter:  Net revenue was $820.3 million compared to $805.9 million the...

2025, AdaptHealth, capitated agreement, preferred provider, Third Quarter (Q3)


Read Full Articlered right arrow icon

Vendors

Philips says it’s maintaining momentum with third quarter results 

November 4, 2025HME News Staff

AMSTERDAM – Royal Philips’ Connected Care business, which includes Sleep & Respiratory Care, saw comparable sales growth of 5.1% in the third quarter of 2025.  Adjusted EBITA margin improved 410 bps to 11.4%, driven by increased sales and productivity, partially offset by tariffs.  The company, as a whole, saw sales of EUR 4.3 billion for the third quarter of 2025, a 3% comparable increase.  Other results for the Group:  Comparable...

2025, Connected Care, Royal Philips, Sleep & Respiratory Care, Third Quarter (Q3)


Read Full Articlered right arrow icon

Providers

Quipt: Structural improvements starting to pay off 

August 12, 2025HME News Staff

CINCINNATI – Quipt Home Medical reported revenue of $58.3 million for the third quarter, a 4.1% decrease compared to the same period last year. It reported revenue of $177 million for the nine months ended June 30, also a 4.1% decrease.  Other financial results:  Adjusted EBITDA for Q3 2025 was $13.7 million (23.5% of revenue) compared to $14.2 million (23.4% of revenue) for Q3 2024, representing a 3.6% decrease.  Adjusted EBITDA of $41 million (23.2% of revenue) for...

2025, Quipt Home Medical, Third Quarter (Q3)


Read Full Articlered right arrow icon

Jason Hollar

Also Noted

Cardinal Health sees ‘broad-based performance’ 

May 5, 2025HME News Staff

DUBLIN, Ohio – Cardinal Health has reported revenues of $54.9 billion for the third quarter fiscal year 2025, flat to the same period last year. The company reported GAAP operating earnings of $730 million and non-GAAP operating earnings of $807 million, a 21% increase, driven by across-the-board segment profit growth. "Our strong momentum continued into our third quarter as our team's ongoing focus on operational execution and value creation led to excellent financial results,"...

2025, Cardinal Health, Financial Results, Third Quarter (Q3)


Read Full Articlered right arrow icon

Vendors

Inogen remains focused on growth, innovation, profitability 

November 7, 2024HME News Staff

GOLETA, Calif. - Inogen reported total revenue of $88.8 million for the third quarter of 2024, a 5.8% increase year over year, driven by higher demand and new customer gains across the domestic and international business-to-business channels.   Those gains were partially offset by lower direct-to-consumer sales and rental revenue.  “We continued to make significant progress on our strategic priorities in the third quarter,” said Kevin Smith, president and CEO. Our...

2024, Financial Results, Inogen, Third Quarter (Q3)


Read Full Articlered right arrow icon